Login
$USGO
$5.07 +$0.44 (9.5%) Close

Consolidated Balance Sheets

In millions of USD, except per-share amounts
Q2 FY2026
As of Jun 30, 2026
Q1 FY2026
As of Mar 31, 2026
Q4 FY2025
As of Dec 31, 2025
Q3 FY2025
As of Sep 30, 2025
Q2 FY2025
As of Jun 30, 2025
Q1 FY2025
As of Mar 31, 2025
Q4 FY2024
As of Dec 31, 2024
Q3 FY2024
As of Sep 30, 2024
Q2 FY2024
As of Jun 30, 2024
Q1 FY2024
As of Mar 31, 2024
Q4 FY2023
As of Nov 30, 2023
Q3 FY2023
As of Aug 31, 2023
Q2 FY2023
As of May 31, 2023
Current assets
Cash and cash equivalents
Restricted cash
Other receivables
Inventories
Prepaid expenses and deferred costs
Prepaid expenses
Total current assets
Exploration and evaluation assets
Operating lease right-of-use assets, net
Property and equipment, net
Total assets
Current liabilities
Accounts payable
Accrued liabilities
Current portion of lease liabilities
Withholdings taxes payable
Income tax payable
Other payables
Total current liabilities
Lease liabilities
Asset retirement obligations
Total liabilities
Stockholders’ equity
Common stock $0.001 par value: 300,000,000 shares authorized as at June 30, 2026 and December 31, 2025; 13,512,860 shares issued and outstanding as at June 30, 2026 and 13,308,985 shares issued and outstanding as at December 31, 2025
Additional paid-in capital
Share issuance obligation
Accumulated deficit
Total stockholders’ equity
Total liabilities and stockholders’ equity

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support